Patent · US Active

Thiadiazole IRAK4 inhibitors

US11702414B2 · kind B2 · utility

1Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 17, 2021
Grant dateJul 18, 2023
Priority date—
Expiry dateAug 5, 2041

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A compound of Formula (I): pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.